Back to search results
NCT06731348

Patient Satisfaction With Opioid Restriction After Urogynecologic Surgery

Enrolling by Invitation
PHASE4Ages 18+InterventionalTreatment
Walter Reed National Military Medical Center
~92 participants
Updated 2025-06-11 on ClinicalTrials.gov
What's tested:restricted opioid prescribingstandard opioid prescribing

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Patient satisfaction with post-operative pain control
Measured over post-operative day 7-10

Conditions

Patient Satisfaction
Opioid Use After Surgery
Urogynecologic Surgery

Explore related trials

Urogynecologic Surgery

Where it's being run

1 sites across 1 states
Maryland1

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Females 18 years of age and older
Scheduled for urogynecologic surgical procedure
Ability to follow study instructions and complete all required follow-up
DEERS eligible
Willing to take the SOC opioid dose or the restricted dose

Exclusion

Ineligible for non-opioid pain medication, including allergy to acetaminophen or NSAIDS
History of opioid abuse determined by asking the potential participant about history of opioid abuse and reviewing potential participant's chart to look for prior or active diagnosis of opioid abuse.
Females who are breastfeeding, pregnant or planning a pregnancy during the study or who think that they may be pregnant at the start of the study, or females of childbearing potential who are unable or unwilling to use a reliable form of contraception during the study
Inability to speak or read English. Non-English speakers will be excluded from this study for ease of being able to allow the principal investigator to communicate with the patients during the consents, initial and all follow-up communication. Some of the questionnaires used have also only been validated in English.

What this trial measures

  • Patient satisfaction with post-operative pain controlpost-operative day 7-10

    Satisfaction with post-operative pain control on post-operative day (POD) 7-10 in participants undergoing urogynecologic surgery who receive either the routine opioid prescribing protocol or the restrictive prescribing protocol.